ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0078

Trends and Disparities in AKI and Septicaemia-Related Mortality in the United States, 1999-2023

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Ali, Muhammad, Dow International Medical College, Karachi, Sindh, Pakistan
  • Nasir, Anas, Sheikh Zayed Medical College, Rahim Yar Khan, Punjab, Pakistan
  • Fatima, Hurmat, Foundation University Medical College, Islamabad, Islamabad Capital Territory, Pakistan
  • Rahman, Saif Ur, Bacha Khan Medical College, Mardan, N.W.F.P, Pakistan
  • Hussain, Dania, United Medical and Dental College, Karachi, Sindh, Pakistan
  • Khurshid, Huzaifa, Khyber Medical College, Peshawar, N.W.F.P, Pakistan
  • Khan, Amal Shahzad, Foundation University Medical College, Islamabad, Islamabad Capital Territory, Pakistan
  • Sher, Sarwat, Rehman Medical College, Peshawar, N.W.F.P, Pakistan
  • Ali, Irtiza, Texas A&M University, College Station, Texas, United States
Background

Acute Kidney Injury (AKI) and septicaemia are interlinked, and research into their shared mortality trends in the United States is needed. Understanding the epidemiology and trends of populations afflicted with these diseases would significantly help enhance management and improve outcomes. We analyze AKI and septicaemia-related mortality in adults aged 65 and older from 1999 to 2023, with additional focus on demographic and geographic factors

Methods

The CDC WONDER Multiple Cause-of-Death Public Use records from 1999 to 2023 were used to analyze mortality trends amongst adults ≥65 years using ICD-10 codes for AKI (N17) and septicaemia (A02.1, A22.7, A26.7, A32.7, A40, A41, A42.7, and B37.7). Age-adjusted mortality rates (AAMR) per 100,000 people, along with annual percent change (APC) and average annual percent change (AAPC), were stratified by year, along with demographic and regional stratifications using Joinpoint regression software.

Results

308,161 AKI and septicaemia-related deaths occurred from 1999 to 2023. Overall, AAMR rose from 14.1 in 1999 to 48.5 in 2023. Significant disparities in mortality rates among different demographic and regional distributions were noted. AAMR increased the most in women (AAPC: 6.2; 95%CI: 5.6 to 7.1) compared to men, non-Hispanic Whites (AAPC: 6.3; 95%CI: 5.6 to 7.3) compared to other races, the West (AAPC: 6.9; 95%CI: 6.1 to 8.1) compared to other census regions, and rural areas (AAPC: 5.1; 95%CI: 4.5 to 6.0) versus urban areas.

Conclusion

An upward trajectory has been seen in AKI and septicaemia-related mortality from 1999 to 2023. This highlights the importance of advancing kidney health research to reduce these rates in the upcoming years.

Digital Object Identifier (DOI)